Connect-BIO: New Opportunities Brought by Artificial Intelligence in the Development of Advanced Therapies
The CQDM invites you to its must-attend event, Connect-BIO, a gathering for researchers and entrepreneurs passionate about artificial intelligence and its impact on the development of advanced therapies.
What to Expect:
- You will have the opportunity to attend inspiring presentations during which Avak Kahvejian CEO at Abiologics, Julien Cottineau, CSO, co-founder at WhiteLab Genomics, Cynthia Lavoie, PhD, MBA, President & CIO at CCRM, Michael Harvey, CDO at Congruence Therapeutics, and David Cotnoir-White CEO & Co-Founder at Modulari-T Bio will discuss how AI has helped or will help them in the development of advanced therapies and share their perspectives on the industry-specific challenges in the sector.
- Networking cocktail
📅 Date: February 20, 2025
🕔 Time: 4:30 PM to 7:30 PM
📍 Location: Archives nationales, 535 Avenue Viger E, Montréal, QC H2L 2P3
Register now 👉 Connect-Bio: Artificial Intelligence and Advanced Therapies Tickets
Why attend?
- Meet key researchers and entrepreneurs from the ecosystem
- Exchange innovative ideas and explore new opportunities with CQDM members
- Discover the future of research and innovation in artificial intelligence applied to advanced therapies
The event will end with a networking cocktail, hosted by our partner ROBIC.
The detailed program will be announced soon.
Save the date – we can’t wait to welcome you!